Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$204.13 - $302.4 $31,844 - $47,174
-156 Closed
0 $0
Q1 2020

May 01, 2020

SELL
$98.9 - $178.34 $1,780 - $3,210
-18 Reduced 10.34%
156 $19,000
Q1 2019

Apr 17, 2019

BUY
$104.82 - $146.73 $1,886 - $2,641
18 Added 11.54%
174 $25,000
Q3 2017

Oct 12, 2017

BUY
$96.72 - $109.26 $15,088 - $17,044
156
156 $17,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.